The Newsroom

Settlement Notices  /  04.03.2019

Exantas Capital Corp Settlement

Exantas Capital Corp. (formerly known as Resource Capital Corp.) (XAN) In re Resource Capital Corp. ...

READ MORE
Investigations  /  04.05.2019

Shareholder Investigation of Corbus Pharmaceuticals

Corbus Pharmaceutical Holdings, Inc. (CRBP) Accused of Faking Clinical Results for Lenabasum According to the ...

READ MORE
Settlement Notices  /  10.15.2018

Regeneron Pharmaceuticals, Inc. Settlement

Regeneron Pharmaceuticals, Inc. Public Employees' Retirement System of Mississippi v. Schleifer, Case No. 656813-2017 (N.Y. ...

READ MORE
Settlement Notices  /  09.24.2018

Acacia Communications, Inc. Settlement

Acacia Communications, Inc. Tharp v. Acacia Communications, Inc., Case No. 17-cv-11504-WGY (D. Mass.) Stipulation Of Settlement ...

READ MORE
Settlement Notices  /  08.09.2018

LRR Energy Securities Litigation Settlement

LRR Energy Hurwitz v. Mullins, No. 1:15-cv-00711-MAK (D. Del) Stipulation of Settlement Addendum to Stipulation ...

READ MORE
Settlement Notices  /  07.27.2018

Saba Software, Inc. Settlement

Saba Software, Inc. In re Saba Software, Inc. Stockholder Litigation, C.A. No. 10697-VCS (Del. Ch.) Stipulation ...

READ MORE
Robbins LLP News  /  04.15.2019

9 Robbins LLP Attorneys Named to 2019 Super Lawyers & Rising Stars

Congratulations 2019 Super Lawyers and Rising Stars! 2019 Super Lawyers Brian J. Robbins – (Top ...

READ MORE
Robbins LLP News  /  05.31.2018

10 Robbins LLP Attorneys Named to 2018 Super Lawyers lists.

George C. Aguilar and Brian J. Robbins have been named as Top 50 Attorneys in ...

READ MORE
Settlement Notices  /  05.03.2018

Apple Inc. Settlement

Apple Inc. In re Apple Inc. E-Book Derivative Litigation, Case No. 1-14-CV-269543 (Cal. Super. Ct. ...

READ MORE
Robbins LLP News  /  01.09.2018

The Firm Welcomes Ms. Rifkin and Ms. Dixon to the Partnership

Ashley R. Rifkin and Jenny L. Dixon have joined the partnership of Robbins LLP. January ...

READ MORE

How can we help you?

CONTACT US TODAY | 1 800 350 6003 or [email protected]

Tell us your concerns